Introduction
Adenosine 5'-triphosphate (ATP)-sensitive K + (K ATP ) channels are inhibited by intracellular ATP and activated by intracellular nucleoside diphosphates, thereby serving as a link between metabolic condition and excitability in various cell types (Ashcroft, 1988; Terzic et al., 1995) . K ATP channels are associated with diverse biological responses such as vasodilatation, insulin secretion, ischaemia-induced cardiac preconditioning, neurotransmitter release and oocyte maturation (Ashcroft, 1988; Terzic et al., 1995) .
K ATP channels are activated by numerous compounds with distinct chemical structures such as benzothiadiazines, guanidine/thiourea derivatives and pyridine derivatives (Edwards & Weston, 1990) . These agents, collectively termed as K + channel openers (KCOs), cause various biological eects through modulation of the dierent K ATP channel-mediated responses (Terzic et al., 1995) . Thus, KCOs can potentially be useful therapeutics. However, they have been rarely utilized for treatments of human diseases, probably because most of the agents non-speci®cally activate the K ATP channels in dierent tissues and thus may cause undesirable side-eects (Ashcroft & Ashcroft, 1990) . The KCOs which are selective for a speci®c organ or tissue might be more preferable for clinical usage. Actually, some of the KCOs do exhibit a certain tissue-speci®city. For example, diazoxide activates the K ATP channels in pancreas and vascular smooth muscle but not in heart (Trube et al., 1986; Escande, 1989; Faivre & Findlay, 1989) . Pinacidil activates cardiac and smooth-muscle K ATP channels but not those in pancreas Standen et al., 1989; Terzic et al., 1995) . It may be important to elucidate the molecular mechanism responsible for such tissue-speci®city' of the KCOs for designing novel useful KCOs.
It is now established that the classical K ATP channels are composed of two distinct subunits: a sulphonylurea receptor (SUR) and BIR (Kir6.2), an inwardly rectifying K + channel (Kir) subunit (Aguilar-Bryan et al., 1995; Inagaki et al., 1995b; Sakura et al., 1995; Isomoto et al., 1996) . When coexpressed with Kir6.2, all of the three types of SUR identi®ed so far (i.e., SUR 1 , SUR 2A and SUR 2B ) form the classical K ATP channels with the same single channel characteristics but distinct KCO sensitivities (Inagaki et al., 1995b; Sakura et al., 1995; Isomoto et al., 1996) . Thus, SURs may be responsible for the dierential eects of KCOs on each K ATP channel. Because SUR 1 , SUR 2A and SUR 2B have been ascribed to the SUR of the pancreatic, cardiac and smooth-muscle K ATP channels, respectively (Inagaki et al., 1995b; Sakura et al., 1995) , the tissue-speci®city of KCOs now can be examined in vitro by measuring the current responses to each drug of heterologously expressed K ATP channels composed of dierent type SUR and Kir6.2.
In this study, we compared the eects of pinacidil and nicorandil on the heterologously expressed SUR 2A /Kir6.2 and SUR 2B /Kir6.2 channels in HEK293T cells. We show that nicorandil4100 times more potently activates the SUR 2B / Kir6.2 channel than the SUR 2A /Kir6.2, while pinacidil activates both channels with similar potency. This result may indicate that nicorandil, compared with pinacidil, acts more speci®cally on vascular smooth muscle than on heart. Because SUR 2A and SUR 2B are divergent only in the last 42 amino acid sequence at their carboxyl-terminal ends, this short portion of SUR 2B may play a critical role in nicorandil-action on the smooth muscle K ATP channel.
Methods
Cloning and functional expression of SUR 2A /Kir6.2 and SUR 2B /Kir6.2 channels BIR (Kir6.2) was cloned from a rat brain cDNA library (Stratagene, La Jolla, CA, USA), while mouse SUR 2A and SUR 2B were from a mouse heart cDNA library (Stratagene, La Jolla, CA, U.S.A.) as previously described (Isomoto et al., 1996) . The nucleotide sequences of all these cDNAs were fully veri®ed and have been reported to the GenBankTM/EBI Data Bank with the accession numbers of D86039, D86037 and D86038, respectively (Isomoto et al., 1996) . The coding region of each cDNA was individually subcloned into an expression vector pcDNA3 (Invitrogen, San Diego, CA, U.S.A.). The plasmid containing Kir6.2 was cotransfected with either SUR 2A or SUR 2B cDNA into HEK293T cells, a human embryonic kidney cell line, by using LipofectAMINE (Gibco, BRL) according to the manufacturer's instructions. Electrophysiological measurements were usually conducted 2 ± 4 days after transfection.
Electrophysiological recordings
The channels expressed in the HEK293T cells were analysed with the cell-attached and the whole-cell variants of the patchclamp method (Hamill et al., 1981) . In either of the con®gurations, pinacidil, nicorandil and glibenclamide were applied to the bath. The tip of the electrodes had a resistance of 2 ± 5 MO after coated with silicon and ®re polished. Currents were measured with a patch clamp ampl®er (Axopatch 200A, Axon Instruments, Inc., Foster City, CA, U.S.A.) and monitored throughout experiments with an analogue-storage oscilloscope (Dual Beam Storage Oscilloscope, Tektronix, Inc., Beaverton, Ore, U.S.A.). For subsequent analyses, currents were recorded on videocassette tapes by using a PCM recorder (VR-10B, Instrutech Corp., Great Neck, NY, U.S.A.). For analysis, the data were reproduced, low pass ®ltered at 1.0 kHz (-3 dB) with an 8-pole Bessel ®lter (Frequency Devices, Harverhill, MA, U.S.A.), and digitized at 3 or 5 kHz with an AD converter (ITC-16, Instrutech corp., NY, U.S.A.). These data were analysed o-line on a computer (Macintosh Quadra 700, Apple Computer Inc., Cupertino, CA, U.S.A.) with commercially available programmes, i.e. Pulse Program (HEKA electronik, Lambrecht, Germany) and Patch Analyst Pro (MT Corporation, Hyogo, Japan). Single channel amplitude was estimated from amplitude histograms. The response of the whole-cell current to pinacidil or nicorandil was measured by subtracting the basal current from that in the presence of these agents. The subtracted current at each concentration of the agent was normalized to that induced by 100 mM pinacidil in each cell, which was 100+10 and 100+30 pA pF 71 (mean+s.e.mean, n=10) at 730 mV in the cells expressing the SUR 2A /Kir6.2 or SUR 2B /Kir6.2 channels, respectively (5.4 mM extracellular K + ). No signi®cant dierence was detected between these two values (P=0.405).
Statistical data are all expressed as mean+s.e.mean. Signi®cance of dierences between two data were assessed with the Student's unpaired t test, and a P value 50.05 was taken to be signi®cant.
Solutions and chemicals
In the cell-attached con®guration, the pipette was ®lled with a solution containing (in mM): KCl 140, MgCl 2 1, CaCl 2 1 and HEPES-KOH 5 (pH 7.4), while the bath was perfused with`i nternal' solution containing (in mM): KCl 140, MgCl 2 2, EGTA-KOH 5 and HEPES-KOH 5 (pH 7.3). For whole-cell recordings, the pipette was ®lled with internal solution containing 3 mM ATP and 100 mM GTP with the concentration of free Mg 2+ adjusted to 1.4 mM according to the stability constant of the Mg-nucleotide complexes (Dawson et al., 1986) . The bath was perfused with a control bathing solution containing (in mM): NaCl 136.5, KCl 5.4, CaCl 2 1.8, MgCl 2 0.53, glucose 5.5 and HEPES-NaOH 5.5 (pH 7.4). Nicorandil was dissolved at 2 M in a glacial acetic acid, pinacidil at 100 mM in 0.1 M HCl and glibenclamide at 10 mM in dimethylsulphoxide. These vehicles on their own did not induce any signi®cant eect on the whole-cell current of the non-transfected and transfected HEK293T cells even at the maximum concentrations used in this study (n=5, for each). These agents were diluted to the desired concentrations with the internal or the control bathing solution for the cellattached and the whole-cell recordings, respectively. Nicorandil was a gift from Chugai-Pharmaceutical Company (Tokyo, Japan). Pinacidil was purchased from RBI (Natick, MA, U.S.A.). ATP and glibenclamide were purchased from Sigma Chemical Co. (St. Louis, MO, U.S.A.) and GTP from Wako Pure Chemical Industries, Ltd. (Osaka, Japan). Other chemicals and materials were obtained from commercial sources.
Results
Single channel characteristics of the SUR 2A /Kir6.2 and SUR 2B /Kir6.2 channels in the presence of pinacidil or nicorandil Table 1 (n=3*5, for each). The t o and t c of the two channels in the presence of pinacidil or nicorandil were practically identical at various potentials.
In the presence of eective concentrations of pinacidil or nicorandil, we observed these channel currents in more than *80% of the cell-attached patch membranes either of the cotransfected cells (n=15 and 18 for the SUR 2A /Kir6.2 and SUR 2B /Kir6.2 combinations, respectively). In the presence of higher concentrations of the KCOs, more than tens of the channels sometimes simultaneously opened, leading to quasimacroscopic current measurement in the cell-attached con®g-uration. Even under these conditions, we could clearly see the activation of the channels with the same single-channel characteristics shortly after application or suciently after washout of the agents when the open probability of the channels was low. In contrast, these KCOs never induced any currents in non-transfected HEK293T cells (n=3) or those transfected with either of Kir6.2 (n=4), SUR 2A (n=5) and SUR 2B (n=5) alone (data not shown). From these data, we concluded that the channel currents shown here were mediated by the expressed SUR 2A /Kir6.2 or SUR 2B /Kir6.2 channels, consistent with previous ®ndings (Inagaki et al., 1996; Isomoto et al., 1996) . In addition, the single-channel characteristics of the SUR 2A /Kir6.2 or SUR 2B /Kir6.2 channels were identical in the presence of pinacidil or nicorandil. These channel currents were completely inhibited by glibenclamide (2 mM), an inhibitor of K ATP channels (data not shown, n=4), as previously found (Inagaki et al., 1996; Isomoto et al., 1996) .
Eects of pinacidil on the SUR 2A /Kir6.2 and SUR 2B /Kir6.2 channels in the whole cell con®guration Figure 2 shows the eect of dierent concentrations of pinacidil on the whole-cell current of HEK293T cells expressing the SUR 2A /Kir6.2 (Figure 2a) or the SUR 2B /Kir6.2 channel (Figure 2b) . The cells were held at 730 mV. In both of the transfected cells, pinacidil at concentration 41 mM induced outward K + currents in a concentration-dependent manner. The K + currents were completely inhibited by glibenclamide (2 mM) (Figure 2b ). Figure 2c shows the relationship between the concentration of pinacidil and the whole-cell SUR 2A /Kir6.2 or SUR 2B /Kir6.2 channel currents. Pinacidil (0.1 ± 100 mM) increased both channel currents in a concentration-dependent manner. High concentrations (4100 mM) of pinacidil showed a weak inhibitory eect on both the channel currents. The relationships were ®tted with the modi®ed Hill equation using the least-squares method:
Relative current Aaf1 KaPinacidil nH g 1 where the relative current is the current normalized to that induced by 100 mM pinacidil in the same cells; A is the maximum relative current attained with pinacidil; K is the apparent dissociation constant of pinacidil; [Pinacidil] , the concentration of pinacidil; and n H the Hill coecient. The a b All these data were estimated from the dwell time histograms for open and closed times in bursts constructed from the traces shown in Figure 1a . Both the open and closed time histograms were satisfactorily ®tted with a single exponential function under each condition. The values indicate the mean+s.e.mean. The number of observations is 3 ± 5 for each of the conditions. values of A, K and n H were 1.05, 9.8 mM and 1.24 for the SUR 2A /Kir6.2 channel; and 1.03, 1.4 mM and 1.42 for the SUR 2B /Kir6.2 channels. Both relationships were very similar but signi®cantly dierent at 1, 3 and 10 mM pinacidil (P=0.0013, 0.0017 and 0.027, respectively). Therefore, pinacidil may activate the SUR 2B /Kir6.2 channel slightly more potently than the SUR 2A /Kir6.2 channel. However, there was a tendency for the SUR 2B /Kir6.2 channel to become desensitized to some extent by high concentrations (i.e., 10 and 100 mM) of pinacidil more frequently than the SUR 2A /Kir6.2 channel (Figure 2a  and b) . Thus, if desensitization had not occurred, the maximum value of SUR 2B /Kir6.2 channel activity induced by 100 mM pinacidil would have been larger than that actually measured. To avoid the in¯uence of desensitization as far as possible, the current values obtained at each concentration of pinacidil were normalized to the peak current value induced by 100 mM pinacidil in each patch. Nevertheless, the data shown in Figure 2c could have been biased to some extent by such desensitization. However, in such a case the relative current values observed in the presence of lower concentrations of pinacidil may have been overestimated. Therefore the real dierence in the sensitivity to pinacidil between the SUR 2A / Kir6.2 and SUR 2B /Kir6.2 channels might be even smaller than that shown in Figure 2c .
Eects of nicorandil on the SUR 2A /Kir6.2 and SUR 2B / Kir6.2 channels in the whole-cell con®guration Figure 3 shows the eect of nicorandil on the whole-cell SUR 2A /Kir6.2 (Figure 3a) and SUR 2B /Kir6.2 channel currents (Figure 3b ). In the cells expressing the SUR 2A / Kir6.2 channels, nicorandil induced an outward current at concentrations 4100 mM. The current induced by 1 mM nicorandil was only *30% of that induced by 100 mM pinacidil. Glibenclamide (2 mM) completely inhibited the pinacidil-current. On the other hand, the SUR 2B /Kir6.2 channel was eectively activated by 1 ± 30 mM nicorandil in a concentration-dependent manner. Nicorandil (30 mM) activated the channel approximately to the same extent as 100 mM pinacidil. Figure 3c shows the relationships between the concentration of nicorandil and the whole-cell SUR 2A / Kir6.2 or SUR 2B /Kir6.2 channel currents. In this graph, the current induced by each concentration of nicorandil was normalized to that induced by 100 mM pinacidil in each cell. The threshold concentration of nicorandil to activate the SUR 2A /Kir6.2 channel was 10 mM. The current evoked by 1 mM nicorandil was only *37+14 (n=3) % of that induced by 100 mM pinacidil. On the other hand, nicorandil (1 ± 100 mM) eectively activated the SUR 2B /Kir6.2 channel. The maximum current of SUR 2B /Kir6.2 channel induced by nicorandil was approximately the same as that by 100 mM pinacidil. At concentrations higher than 100 mM, nicorandil showed some inhibitory eect on the SUR 2B /Kir6.2 channel. Therefore, nicorandil showed almost the same potency and ecacy as pinacidil in activating the SUR 2B /Kir6.2, but was more than 100 times less potent than pinacidil in activating the SUR 2A /Kir6.2 channels.
Discussion and conclusions
We showed for the ®rst time that nicorandil, but not pinacidil, activates the SUR 2B /Kir6.2 channel 4100 times more potently than the SUR 2A /Kir6.2 channel. The partition coecient of pinacidil in octanol/phosphate buer (pH 7.4) is 0.99 (from Dr Erling N. Petersen, Leo Pharmaceutical Products Ltd.), while that of nicorandil in octanol/phosphate buer (pH 7.5) is 0.78 (from Chugai Pharmaceutical Company). Therefore, pinacidil is more hydrophobic than nicorandil at neutral pH, raising the possibility that the two agents may achieve dierent concentrations at the receptor sites of the channels if applied to the bathing solution at the same concentration. However, this does not aect our conclusion because we compared the sensitivities of the SUR 2A /Kir6.2 and SUR 2B /Kir6.2 channels to each drug, but not the eects of pinacidil and nicorandil on each type of channel. SUR 2A and SUR 2B are the splicing variants of the same gene, both of which are composed of 1546 amino acids and dier only in the last 42 amino acid residues in their carboxylterminal ends (i.e. aa. 1505 ± 1546) (Isomoto et al., 1996) . Therefore, the carboxyl-terminal regions of SUR 2A and SUR 2B seem to play a critical role in the dierent sensitivity of the SUR 2A /Kir6.2 and SUR 2B /Kir6.2 channels to nicorandil.
We previously found that diazoxide, a potent activator of the SUR 1 /Kir6.2 channel (Inagaki et al., 1995b) , activates the SUR 2B /Kir6.2, but not SUR 2A /Kir6.2, channel (Isomoto et al., 1996; Inagaki et al., 1996) . Because the amino acid sequence within the alternative region of mouse SUR 2B is 74% and 33% identical to those of the corresponding regions of rat SUR 1 and mouse SUR 2A , respectively, it was postulated that the carboxyl-terminal region is involved in dierential activation of SUR/Kir6.2 complex channels by diazoxide (Isomoto et al., 1996) . Diazoxide does not activate the SUR 2A /Kir6.2 channel, while neither nicorandil nor pinacidil can activate SUR 1 /Kir6.2 channel (Inagaki et al., 1995b; data not shown) . Therefore, the region shared by SUR 2A and SUR 2B (i.e. aa. 1 ± 1504) appears to be crucial for the action of both pinacidil and nicorandil. Taken together, the whole sequence of SUR 2B is necessary for nicorandil- action, while the carboxyl-terminal region of SUR 2B may enhance the sensitivity of the SUR/Kir6.2 complex channels to nicorandil. Alternatively, it is also possible that the divergent part of SUR 2A suppresses the nicorandil action. The carboxyl-terminal regions of SUR 2A and SUR 2B may not be involved in the action of pinacidil.
However, unknown is how this short segment of the Cterminus of SUR 2B is involved in actions of nicorandil and diazoxide on the SUR/Kir6.2 channels. This region might be a part of the receptor sites for the KCOs, or might indirectly aect the function of the receptor sites for the KCOs located in other parts of SUR. In this regard, it should be noted that the SUR 2B /Kir6.2 channel is more eectively inhibited by Mg 2+ -free than -bound forms of ATP, while the SUR 2A /Kir6.2 channel is equally sensitive to both forms of ATP (Isomoto et al., 1996) . Recently, Tucker et al. (1997) showed that the inhibitory ATP-binding site may be a lysine residue (K185) locating in the proximal region of the C-terminus of Kir6.2. The SUR (SUR 1 in their study) interacting with Kir6.2 increases the sensitivity of the channel to intracellular ATP. Thus, SURs modulate the sensitivity of the interaction between the lysine residue in Kir6.2 and ATP. It was postulated that the 42 amino acids at the C-termini of SUR 2s may play important roles in dierential regulation of the ATP-binding site of Kir6.2 by Mg-free and Mg-bound forms of ATP (Isomoto et al., 1996) . It is also known that most of KCOs activate K ATP channels by modulating the sensitivity of channels to intracellular nucleotides (Terzic et al., 1995) . Therefore, there might be a similar basis for the action of some KCOs and intracellular ATP. However, further studies are necessary to elucidate the molecular mechanism by which the carboxyl-termini of SUR 2A and SUR 2B produce the dierent sensitivities to nicorandil of the SUR 2A /Kir6.2 and SUR 2B /Kir6.2 channels. SUR 2A forms the cardiac or skeletal-muscle type classical K ATP channel with Kir6.2 (Inagaki et al., 1996) . On the other hand, SUR 2B is likely to form a vascular K + channel in vivo by coupling with Kir6.1 (Yamada et al., 1997), another Kir subunit whose amino acid sequence is *70% identical to that of Kir6.2 (Inagaki et al., 1995a) . This vascular K + channel, often referred to as the nucleotide diphosphate-dependent K + (K NDP ) or the small conductance K ATP channel, serves as the major receptor site for KCOs in vascular smooth muscle (Kajioka et al., 1991; Beech et al., 1993; Kamouchi & Kitamura, 1994; Zhang & Bolton, 1996) . The SUR 2B /Kir6.1 channel shows the same pharmacological properties as the SUR 2B /Kir6.2 channel (Yamada et al., 1997) . It is, however, dicult to compare quantitatively the tissue speci®city of various KCOs using SUR 2A /Kir6.2 and SUR 2B /Kir6.1 channels, because they dier in the single channel characteristics and nucleotide regulations (Isomoto et al., 1996; Yamada et al., 1997) . The present data show that a quantitative comparison of the eects of various KCOs can be performed in vitro by using heterologously expressed K ATP channels composed of dierent types of SUR and Kir6.2. This method, when combined with site-directed mutagenesis, will more precisely delineate the molecular mechanism responsible for the subtype speci®c action of KCOs, and thus will provide a future strategy to develop novel KCOs . STANDEN, N.B., QUAYLE, J.M., DAVIES, N.W., BRAYDEN, 
